medline.ch Neurologie Multiple Sklerose

	Therapeutic plasma exchange in people with multiple sclerosis: A province-wide study. Mult Scler Relat Disord Vyas MV, Raza S, Everett K, Odugbemi T, Momen A, Taghdiri F, Fang J, Rotstein DL, Oh J, Pavenski K. PMID: 42607546 [PubMed - as supplied by publisher]
	Data-Driven Fatigue Trajectories in Multiple Sclerosis and Their Predictors. Neurol Neuroimmunol Neuroinflamm Cruciani A, Olivieri E, Christensen R, Al-Araji S, Fourali S, Hamed W, He A, Kanber B, Maccarrone D, Mohamud S, Nistri R, Passalis A, Pozzilli V, Prados F, Yam C, Yiannakas MC, Thompson AJ, Barkhof F, Toosy AT, Ciccarelli O. PMID: 42607283 [PubMed - indexed for MEDLINE]
	Comparative analysis of multiple sclerosis burden in China and India from 1990 to 2021 based on the Global Burden of Disease Study 2021. Immunol Res Cai ZL, Dong F, Ma J, Wang D, Yi W, Cao L, Cai ZY. PMID: 42606789 [PubMed - indexed for MEDLINE]
	Investigating functional brain networks in multiple sclerosis patients: a graph theory approach for evaluating working memory impairment. Brain Inform Yousefi S, Daliri MR. PMID: 42606763 [PubMed]
	Survey of the frequency of polypharmacy in multiple sclerosis patients: a study from the nationwide MS registry of Iran (NMSRI)-Guilan. Neurodegener Dis Manag Asgari S, Saberi A, Daliri H, Atefrad S, Farzin M. PMID: 42606735 [PubMed - as supplied by publisher]
	Therapeutic Advances and Biomarkers in Multiple Sclerosis. Curr Neuropharmacol Panos LD. PMID: 42605926 [PubMed - as supplied by publisher]
	Perceived Fatigability and Fall Risk in Aging with and without Multiple Sclerosis: A Prospective Cohort Study. J Gerontol A Biol Sci Med Sci Luo DH, Holtzer R. PMID: 42605068 [PubMed - as supplied by publisher]
	Foreword for pathobiology-guided diagnostic advances, biomarker discovery, and emerging therapeutic strategies in progressive multiple sclerosis. Dis Mon Leikin JB. PMID: 42603760 [PubMed - as supplied by publisher]
	Effectiveness of escalation versus early high-efficacy therapies on progression independent of relapse activity in multiple sclerosis: a Danish nationwide study. BMJ Neurol Open Varju E, Pontieri L, Mahler MR, Magyari M, DMSG Study Group. PMID: 42602817 [PubMed]
	Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study. Ther Adv Neurol Disord Oreja-Guevara C, Gómez-Estévez I, Agüado García L, Martín Martínez J, Gómez Gutiérrez M, Gascón Giménez F, Agüera Morales E, Meca-Lallana V, Barrero Hernández FJ, González Quintanilla V, Romero Pinel L, Delgado Gil V, Durán Ferreras E, Blasco Quílez R, Meca-Lallana J, Landete Pascual L, Aladro-Benito Y, Boyero Durán S, Gracia Gil J, Caminero Rodríguez AB, Cano Orgaz AT, Eichau Madueño S, Querol Pascual MR, Otano Martínez M, Alonso Torres AM, Calles Hernández C, López Real A, Ares Luque A, Lorenzo González JR, Gómez Vicente L, Díaz Sánchez M. PMID: 42602134 [PubMed]
	Exploratory multi-omics analysis suggests context-dependent immune responses to vitamin D(3) supplementation in PBMCs of multiple sclerosis patients. Front Immunol Tripathi T, Gospodarska E, Geran R, Sperber PS, Schmitz-Hübsch T, Paul F, Carlberg C. PMID: 42601952 [PubMed - indexed for MEDLINE]
	Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data. J Neurol Neurosurg Psychiatry Zhu C, Vukusic S, Kalincik T, Mathey G, Kermode AG, Maillart E, Lechner-Scott J, Le Page E, Roos I, Ciron J, Kubala Havrdova E, Horakova D, De Sèze J, Skibina O, Ruet A, Yetkin MF, Labauge P, Habek M, Kwiatkowski A, Baghbanian SM, Zephir H, Meca-Lallana JE, Valero López G, Papeix C, Gerlach O, Defer G, Fabis-Pedrini M, Carroll WM, Lebrun-Frenay C, Hodgkinson S, Moreau T, Laureys G, Laplaud DA, Prat A, Berger E, Lapointe E, Clavelou P, Ampapa R, Thouvenot E, Stetkarova I, Heinzlef O, Stourac P, Pelletier J, Foschi M, Al Khedr A, D'Amico E, Casez O, Alroughani R, Bourre B, Brecl Jakob G, Creange A, Ozakbas S, David T, John N, Magy L, Camdessanché JP, Moulin S, Doghri I, Sarov Riviere M, Hankiewicz K, Pottier C, Manchon E, Aboab J, Tchikviladze M, Nifle C, Merlo D, Monif M, Zhou Z, Foong YC, Jokubaitis V, van der Walt A, Butzkueven H, OFSEP and MSBase investigators. PMID: 42601218 [PubMed - as supplied by publisher]
	PARP inhibition attenuates neuroinflammation and demyelination in a rat model of multiple sclerosis: A longitudinal [(11)C]PBR28 TSPO PET imaging study. Neurotherapeutics Li G, Antunes IF, Ming Z, Wu C, Cornelissen B, de Vries EF. PMID: 42600545 [PubMed - as supplied by publisher]
	Natural flavonoids in multiple sclerosis: molecular insights and emerging therapeutic strategies. Front Immunol Abusaliya A, Al Shamsi M, Orsud H, Al Rasbi Z, Zoughbor S, Joher N. PMID: 42597552 [PubMed - indexed for MEDLINE]
	Genetic Algorithm-Optimized support vector machine for MRI-based multiple sclerosis diagnosis from white matter lesion features. Digit Health Hosseiny RS, BaniRostam T. PMID: 42597486 [PubMed]
	Diagnosis of syphilitic chorioretinopathy in a patient with a history of relapsing-remitting multiple sclerosis and previous optic neuritis. BMJ Case Rep Kamali Zonouzi S, Micieli J. PMID: 42595385 [PubMed - indexed for MEDLINE]
	Genetic Risk in Multiple Sclerosis: Susceptibility, Modifiers and Unresolved Questions. Neurol Ther He J, Blackburn NB, Jokubaitis VG. PMID: 42593635 [PubMed - as supplied by publisher]
	Incidence, Patterns and Predictors of Alemtuzumab-Induced Thyroid Dysfunction in Patients With Multiple Sclerosis: A Northern Ireland Cohort Study. Clin Endocrinol (Oxf) Flynn DO, Kennedy F, Hughes S, Magill F, Mc Donnell GV, Black N, Darrat M, Mullan G, Darcy R, McCance DR, Spence K, Johnston PC. PMID: 42592679 [PubMed - as supplied by publisher]
	Oxidative stress, depressive symptoms, disability, cognitive outcomes and hand dexterity in relapsing-remitting multiple sclerosis patients with mild/moderate disability. IBRO Neurosci Rep Mosaddeghi-Heris R, Taheri N, Talebi M, Naseri A. PMID: 42592261 [PubMed]
	Inter-assay variability in anti-JC virus serology in the era of natalizumab biosimilars: implications for PML risk stratification. Front Immunol Caminero AB, Oreja-Guevara C. PMID: 42592097 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 44694

Seite 1 von 2235

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung